Callan Family Office’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Callan Family Office's BMY Position: Q2 2026 in Review
Callan Family Office increased its Bristol-Myers Squibb (BMY) stake by 37% in Q2 2026, buying an estimated $966K and bringing the position to 62,042 shares worth $3.57M. The position accounts for 0.07% of the portfolio, ranked #253.
Callan Family Office first reported a position in BMY in Q1 2023 and has held it in 9 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Callan Family Office held 62,042 shares of Bristol-Myers Squibb worth $3.57M as of Q2 2026.
- Callan Family Office bought 16,816 Bristol-Myers Squibb shares in Q2 2026, an estimated $966K.
- Bristol-Myers Squibb made up 0.07% of Callan Family Office's portfolio in Q2 2026, its #253 holding.
- Callan Family Office first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 9 quarters since.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.